Addiction. Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine

Similar documents
Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic

Opioid Use Issues: All the Players

Neurobiology of Drug Abuse and Addiction PSYC 450

Overview. APPLIED PREVENTION & intervention STRATEGIES. APPLIED PREVENTION & intervention STRATEGIES

Substance Use Disorders

A Comprehensive Model of Stepped Care for Substance Misuse Prevention on a College Campus

Critiquing the Construction of Addiction: Dependence, Disorder and the DSM V

Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain

Commi ee Lecture: Neurocogni ve Disorders TBI : Trauma c Brain Disorders. William L. Bograkos, MA, DO, FACOEP

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی

Opiate Use Disorder and Opiate Overdose

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Chapter 7. Screening and Assessment

THE ADDICTIVE BRAIN SC 212 JANUARY 3, 2017 JOHN BUSH

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW

Alcohol Misuse Clinical Pathway Outline

Module Three Screening and Assessment V

History of Present Illness (HPI) Assessment and Plan Template

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

The Role of the PDMP: Foundational Knowledge and Best Practices

590,000 deaths can be attributed to an addictive substance in some way

Clinical and public health significance of the proposed changes to the diagnosis of alcohol abuse and dependence in DSM-5

2/21/2018. What are Opioids?

Acute General Medical and Surgical Admission:

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Appendix F Federation of State Medical Boards

Clinical Evaluation: Assessment Goals

Important Information

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION

Implementation of Screening and Interventions for Unhealthy Alcohol Use. Dan Jonas, MD, MPH

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

March 29, 2017 Debra K. Smith, Ph.D. St. Charles Hospital Port Jefferson, New York

Neurobiology of Addiction

Do I Have a Drinking Problem?

Classification of Abuse-Related Events in Analgesic Clinical Trials: Recommendations and Research Agenda

BRAIN MECHANISMS OF REWARD AND ADDICTION

KAP Keys. For Clinicians. Based on TIP 24 A Guide to Substance Abuse Services for Primary Care Clinicians. CSAT s Knowledge Application Program

Management of Tobacco Dependence. Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur

A look at Marijuana in 2014

HIV and alcohol use: why is risk reduction in alcohol use important in HIV care?

11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

Evidence based Practices

Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing

Neocortex. Hemispheres 9/22/2010. Psychology 472 Pharmacology of Psychoactive Drugs. Structures are divided into several section or lobes.

Anabolic Androgenic Steroids and the Brain

Restoration of Parenting Ability Through Treatment for Substance Use Disorders

Substance Use Disorders: Diagnosis and Treatment in Primary Care

Survey of Temporary Assistance For Needy Families (TANF) Recipients

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

Common Diagnosis Codes and Tips for Coding Nicotine Use/

Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

substance use and mental disorders: one, the other, or both?

HOUSE Calls. Addiction Medicine. Winter Published by the Alachua County Medical Society

Feeding and Eating Disorders

Shatter the Stigma J e s s i c a C a n d e l a r i a L i p s e y, M S W R e g i s t e r e d C l i n i c a l S o c i a l W o r k I n t e r n

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

Understanding Addiction

Substance Abuse and Addiction Issues The Science Behind Addiction. John B. Woods. Recovery Specialists, LLC

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Hot Topics in Addiction Medicine. Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

processes in the central nervous system (CNS), affecting many of the during the course of ethanol treatment. Ethanol stimulates the release of

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

What are Substance Use Disorders?

Hospitals Role in Addressing the Opioid Crisis

Advances In Measurement Modeling: Bringing Genetic Information Into Preventive Interventions And Getting The Phenotype Right

Tapering Opioids Best Practices*

ADDICTION MEDICINE. Objectives

The Biology of Addiction

Hospital Based Opioid Management A case based, peer discussion

BASIC VOLUME. Elements of Drug Dependence Treatment

WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS

The Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth

Care Speranza MS, LAC, RN, CCS, PLPC, AADC 7/3/2018

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

Responding to the Opioid Epidemic: Behavioral Health Specialists Role on the Interprofessional Team

Basic definition and Classification of Anhedonia. Preclinical and Clinical assessment of anhedonia.

The Neuroscience of Addiction: A mini-review

Defining & diagnosing addiction

Substance use and addictive disorders in Palliative care

FOUR SELF-TESTS: SEXUAL ADDICTION, SEXUAL ANOREXIA, BINGE-PURGE, COLLATERAL INDICATORS

Optimizing Opioid Dependence Treatment A Guideline for Pharmacists

The Neurobiology of Drug Addiction

Opioid Overdose Epidemic A Crises and Opportunity

Addiction: definition and implications

What is addiction and what can businesses do about it?

Michael P. Botticelli Director Office of National Drug Control Policy Executive Office of the President 1650 Pennsylvania Ave NW Washington, DC 20502

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Neurobiology of Addiction. Jon E. Grant, JD, MD, MPH Professor University of Chicago

Eighth Edition. Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas

An Internist s Guide to Unhealthy Alcohol Use. Ryan Graddy, MD JHU SOM

Initial Substance Use Assessment

Tobacco Dependence Assessment and Treatment

Treating Obesity as an Addiction (Can Obesity be Understood as a Bona Fide Mental Illness?)

Addiction: The Disease. Joseph A. Troncale, MD FASAM

Recap: Introduction & History of Motivation & Emotion (Lecture 01 - Ch 1 & 2, Reeve, 2009)

America is a drugged society

Transcription:

Addiction Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine Twitter: @rcwallermd

Objectives Understand the Concept of Addiction

Survival FOOD WATER DOPAMINE

Neurobiology Ant. Cingulate Gyrus Nucleus Accumbens amygdala Ventral Tegmental Area Periaqueductal Grey

Behavior Lack of Dopamine Survival Mode Craving Primal Action

Behavior Diagnosis based in the description of behavior Aberrant behavior should be expected Therefore behavior is a symptom not a frustration

Treatments Since lack of dopamine is the basis for driving the behavior Augmentation of Dopamine makes sense Buprenorphine and Methadone safely increase dopamine This allows for stabilization of craving Allowing for behavioral therapy to be effective

ASAM Definition Addiction affects neurotransmission and interactions within reward structures of the brain, including the amygdala basal forebrain nucleus accumbens anterior cingulate cortex Motivational hierarchies are altered and addictive behaviors, which may or may not include alcohol and other drug use, supplant healthy, self-care related behaviors.

ASAM Definition cont. Genetic factors account for about half of the likelihood that an individual will develop addiction. Culture also plays a role in how addiction becomes Environmental factors interact with the person s biology and affect the extent to which genetic factors exert their influence.

Diagnostic criteria Impaired control of the substance 1. 2. 3. 4. Substance is often taken in larger amounts or over a longer period than was intended. There is a persistent desire or unsuccessful efforts to cut down or control substance use. A great deal of time is spent in activities necessary to obtain the substance, use the substance, or recover from its effects. Craving, or a strong desire or urge to use the substance.

Diagnostic Criteria Social impairment 5. 6. 7. Recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home. Continued substance use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effect of the substance. Important social, occupational, or recreational activities are given up or reduced because of substance use.

Diagnostic Criteria Risky use of substance 8. 9. Recurrent substance use in situations in which it is physically hazardous. Continued substance use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance.

Diagnostic Criteria Pharmacological criteria 10. Tolerance, as defined by either of the following: A need for markedly increased amounts of the substance to achieve intoxication or desired effect. A markedly diminished effect with continued use of the same amount of the substance. 11. Withdrawal, as manifested by either of the following: The characteristic substance withdrawal syndrome as defined by the DSM-V The substance(or a closely related substance) is taken to relieve or avoid withdrawal symptoms.

Case Patient is a 23 year old male with history of taking up to 30 Percocet a day for the last year. He has missed 2 appointments and yelled at the front desk staff numerous times. He states that if he does not get his medication here that he will just go somewhere else.

Question What is the most appropriate next step? Fire the patient and tell him to get another doctor Write him for 30 Percocet a day Do an addiction intake or referral and give him the options for treatment Pick another job

References Principles of Addiction Medicine, 4 th edition 2009 Principles of Neural Science, 5 th edition 2012